Funicular Funds LP 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-01-08 6:17 pm Unchanged | 2023-07-06 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 81,279 5.590% | 0 (Unchanged) | Filing |
2023-07-06 4:08 pm Unchanged | 2023-07-06 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 81,279 9.650% | 0 (Unchanged) | Filing |
2022-09-22 09:01 am Purchase | 2022-09-15 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 81,279 9.990% | 15,998 (+24.51%) | Filing |
2022-08-24 4:20 pm Purchase | 2022-08-24 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 65,281 8.000% | 6,826 (+11.68%) | Filing |
2022-07-19 4:30 pm Purchase | 2022-07-15 | 13D | Forte Biosciences, Inc. FBRX | Funicular Funds LP | 58,455 9.900% | 58,455 (New Position) | Filing |